UBS Group
XRAY icon

UBS Group’s Dentsply Sirona XRAY Stock Holding History

UBS Group’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.7M Buy
2,302,913
+600,933
+35% +$7.49M ﹤0.01% 2282
2025
Q4 		$19.5M Buy
1,701,980
+662,000
+64% +$7.77M ﹤0.01% 2616
2025
Q3 		$13.2M Sell
1,039,980
-640,635
-38% -$9.3M ﹤0.01% 2996
2025
Q2 		$26.7M Buy
1,680,615
+1,043,282
+164% +$15.6M ﹤0.01% 2083
2025
Q1 		$9.52M Sell
637,333
-24,949
-4% -$442K ﹤0.01% 3084
2024
Q4 		$12.6M Buy
662,282
+391,411
+145% +$8.28M ﹤0.01% 2814
2024
Q3 		$7.33M Sell
270,871
-29,404
-10% -$751K ﹤0.01% 2676
2024
Q2 		$7.48M Buy
300,275
+87,793
+41% +$2.52M ﹤0.01% 2479
2024
Q1 		$7.05M Buy
212,482
+150,319
+242% +$5.14M ﹤0.01% 2595
2023
Q4 		$2.21M Sell
62,163
-116,262
-65% -$3.69M ﹤0.01% 3706
2023
Q3 		$6.09M Sell
178,425
-21,063
-11% -$801K ﹤0.01% 2388
2023
Q2 		$7.98M Sell
199,488
-16,020
-7% -$637K ﹤0.01% 2149
2023
Q1 		$8.47M Buy
215,508
+71,305
+49% +$2.62M ﹤0.01% 2019
2022
Q4 		$4.59M Buy
144,203
+109,591
+317% +$3.3M ﹤0.01% 2586
2022
Q3 		$982K Sell
34,612
-38,568
-53% -$1.32M ﹤0.01% 3762
2022
Q2 		$2.61M Sell
73,180
-174,181
-70% -$7.04M ﹤0.01% 2918
2022
Q1 		$12.2M Buy
247,361
+51,250
+26% +$2.71M ﹤0.01% 1794
2021
Q4 		$10.9M Sell
196,111
-92,656
-32% -$5.1M ﹤0.01% 2068
2021
Q3 		$16.8M Buy
288,767
+79,032
+38% +$4.87M 0.01% 1638
2021
Q2 		$13.3M Sell
209,735
-27,368
-12% -$1.8M ﹤0.01% 1806
2021
Q1 		$15.1M Sell
237,103
-5,598
-2% -$325K 0.01% 1624
2020
Q4 		$12.7M Buy
242,701
+85,900
+55% +$4.24M ﹤0.01% 1675
2020
Q3 		$6.86M Sell
156,801
-29,245
-16% -$1.29M ﹤0.01% 1914
2020
Q2 		$8.2M Buy
186,046
+106,131
+133% +$4.49M ﹤0.01% 1667
2020
Q1 		$3.1M Buy
79,915
+26,341
+49% +$1.34M ﹤0.01% 2350
2019
Q4 		$3.03M Buy
53,574
+5,534
+12% +$309K ﹤0.01% 3123
2019
Q3 		$9.61M Sell
48,040
-64,056
-57% -$3.44M ﹤0.01% 1794
2019
Q2 		$6.54M Buy
112,096
+13,284
+13% +$714K ﹤0.01% 2114
2019
Q1 		$4.9M Buy
98,812
+58,995
+148% +$2.6M ﹤0.01% 2217
2018
Q4 		$1.48M Sell
39,817
-44,034
-53% -$1.6M ﹤0.01% 3325
2018
Q3 		$3.17M Buy
83,851
+36,735
+78% +$1.53M ﹤0.01% 2774
2018
Q2 		$2.06M Sell
47,116
-154,501
-77% -$7.26M ﹤0.01% 3135
2018
Q1 		$10.1M Buy
201,617
+26,951
+15% +$1.59M ﹤0.01% 1669
2017
Q4 		$11.5M Buy
174,666
+30,867
+21% +$1.96M ﹤0.01% 1607
2017
Q3 		$8.6M Sell
143,799
-50,822
-26% -$3.02M ﹤0.01% 1730
2017
Q2 		$12.6M Buy
194,621
+53,601
+38% +$3.39M 0.01% 1345
2017
Q1 		$8.8M Sell
141,020
-23,588
-14% -$1.42M ﹤0.01% 1611
2016
Q4 		$9.5M Buy
164,608
+16,144
+11% +$954K 0.01% 1540
2016
Q3 		$8.82M Sell
148,464
-11,425
-7% -$702K 0.01% 1522
2016
Q2 		$9.92M Sell
159,889
-1,012
-0.6% -$62.3K 0.01% 1390
2016
Q1 		$9.92M Buy
160,901
+129,755
+417% +$7.65M 0.01% 1333
2015
Q4 		$1.9M Sell
31,146
-10,956
-26% -$652K ﹤0.01% 2844
2015
Q3 		$2.13M Buy
42,102
+9,839
+30% +$524K ﹤0.01% 2679
2015
Q2 		$1.66M Sell
32,263
-11,672
-27% -$604K ﹤0.01% 3149
2015
Q1 		$2.24M Sell
43,935
-18,564
-30% -$957K ﹤0.01% 2827
2014
Q4 		$3.33M Buy
+62,499
New +$3.18M ﹤0.01% 2430

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

UBS Group's XRAY Position: Q1 2026 in Review

UBS Group increased its Dentsply Sirona (XRAY) stake by 35% in Q1 2026, buying an estimated $7.49M and bringing the position to 2,302,913 shares worth $26.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2282.

UBS Group first reported a position in XRAY in Q4 2014 and has held it in 46 quarters since. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • UBS Group held 2,302,913 shares of Dentsply Sirona worth $26.7M as of Q1 2026.
  • UBS Group bought 600,933 Dentsply Sirona shares in Q1 2026, an estimated $7.49M.
  • Dentsply Sirona made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2282 holding.
  • UBS Group first reported a position in Dentsply Sirona in Q4 2014 and has held it in 46 quarters since.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.